Navigation Links
Global CVD leaders call the world to action - 25 by 2025 - from the World Congress of Cardiology

The Global Cardiovascular Disease Taskforce called on the 11,000 World Congress of Cardiology delegates in Dubai, and the cardiovascular disease (CVD) community at large, to support the adoption of a global goal to reduce premature non-communicable disease (NCD) mortality by 25 per cent by 2025. The Task Force which is made up of leadership from the world's largest CVD organizations including the American Heart Association, American College of Cardiology, European Heart Network, European Society of Cardiology and the World Heart Federation is committed to reducing the global burden of CVD.

As the leading cause of death worldwide, NCDs are responsible for more than 36 million deaths each year. Nearly half of these 17.3 million are due to CVD, a number that fails to fully reflect the social and economic impact on families, communities and countries. Yet NCDs and CVD specifically, continues to be viewed as a "lifestyle" disease primarily afflicting those in high-income countries. In fact, the greatest CVD burden falls on low- and middle-income countries where 80% of all CVD deaths occur and is increasingly impacting people during their most productive years. The enormous human and financial cost associated with CVD led to a joint CVD effort to bring CVD and other NCDs to the attention of global leaders outside of the traditional health sector.

This call was answered in September 2011 when world leaders gathered for the second ever United Nations High-level Meeting on a health issue, to discuss the growing epidemic of NCDs and make a concerted commitment to halt and reverse the NCD burden. Formalized in a Political Declaration on NCDs, governments made a set of commitments to reduce this burden through a comprehensive framework inclusive of global targets.

"The set of global targets and indicators to be reviewed and potentially adopted at the World Health Assembly the annual General Meeting of the World Health Organization in Geneva is the first and most important step in creating global change," said American Heart Association CEO, Nancy Brown. Task force member and President of the World Heart Federation Professor Sidney C. Smith Jr., continued: "The Global CVD Taskforce strongly supports keeping the first target of reducing premature NCD mortality 25 percent by 2025 and are aligning with the broader NCD community in renaming it an overarching goal. A global mortality goal will provide a shared vision of NCDs for all stakeholders and ensure that the world works together to address this global burden."

Under the direction of the WHO, relevant stakeholders, including non-governmental organizations (NGOs) and governments, were invited to comment up until 19 April on these proposed targets. "With CVD as the largest single contributor to global mortality and accounting for nearly half of the 36 million NCD deaths, achieving these goals will require partnerships at all levels" stated David Wood of the European Society of Cardiology. "We have the opportunity of a lifetime to make meaningful change in our home, country, and in the world by calling for the global target, or goal, of a 25 per cent reduction in premature NCD mortality by 2025."

"The truly devastating impact of cardiovascular diseases to families and economies, requires immediate action on the part of all stakeholders most notably the World Health Organization" said Dr William Zoghbi, President of the American College of Cardiology.

"Health is central to a country's economic growth" says Dr Hans Stam, President of the European Heart Network, "and its significance in sustainable development can no longer be ignored. Health cannot be neglected and it is our hope that Member States answer this call."

Contact: Charanjit Jagait
World Heart Federation

Related medicine news :

1. Scientists rewrite rulebook on breast cancer in landmark global study
2. International breast health global summit will focus on supportive care and quality of life
3. Global, common approach to pharmaceutical supply chain integrity the focus of workshop
4. Global cardiology leaders meet in Dubai
5. Canada should play a role in addressing the global cancer epidemic
6. NIH awards $20 million over 5 years to train next generation of global health researchers
7. Malarias Global Death Toll Much Higher Than Thought
8. Global conference on stem cell therapy for heart disease to be held Jan. 25-27 in NYC
9. Global Study Finds Drug Abuse Highest in Richer Nations
10. IBD emerges as a global disease
11. Are Global Market Forces Linked to Obesity Epidemic?
Post Your Comments:
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever ... Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation ... as home to some of the world’s leading providers of cereal and other breakfast ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events ... turn to unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. ... tools for healthy coping following a traumatic event. , Trauma sufferers tend to feel ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology: